+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Chemotherapy Induced Anemia - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Anemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gallbladder Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Gallbladder Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Hairy Cell Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hairy Cell Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anaplastic Astrocytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Astrocytoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bevacizumab - Biosimilar Insight, 2025 - Product Thumbnail Image

Bevacizumab - Biosimilar Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Cancer Pain Management - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025 - Product Thumbnail Image

chemotherapy-induced Bone Marrow Toxicities - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Melanoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
HPV-induced Cutaneous Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

HPV-induced Cutaneous Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
TGF-Beta-2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

TGF-Beta-2 Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more